Who owns Northwest Biotherapeutics In?
- Ticker: NWBO
- CUSIP Number: 66737P600
Tip: Access positions for across all investors
Analyze quarterly positions in Northwest Biotherapeutics In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Northwest Biotherapeutics In stock
Who bought or sold Northwest Biotherapeutics In this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Moloney Securities Asset Management | 489k | $134k | 6% | Dec 2024 |
|
| Opus Capital Group | 60k | $17k | 0% | Dec 2024 |
|
| Williams Jones Wealth Management | 27k | $7.4k | -23% | Dec 2024 |
|
| Ethos Financial Group | 24k | $6.5k | 0% | Dec 2024 |
|
| AlphaMark Advisors | 14k | $4.0k | 0% | Dec 2024 |
|
| Advisors Management Group | 10k | $3.0k | 0% | Dec 2024 |
|
| Kitzinger Lautmann Capital Management | 10k | $2.7k | 0% | Dec 2024 |
|
| Coston, McIsaac & Partners | 1.0k | $0 | 0% | Dec 2024 |
|
| Hantz Financial Services | 250.00 | $0 | 0% | Dec 2024 |
|
Who sold out of Northwest Biotherapeutics In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Lee, Danner & Bass | Sep 2024 | 20k | $6.0k |
| MAI Wealth Advisors | Sep 2024 | 20k | $6.4k |
| Sentinus | Jun 2024 | 13k | $5.5k |